Ocular Therapeutix (OCUL) Debt to Equity (2016 - 2025)
Historic Debt to Equity for Ocular Therapeutix (OCUL) over the last 13 years, with Q4 2025 value amounting to $0.11.
- Ocular Therapeutix's Debt to Equity fell 4981.34% to $0.11 in Q4 2025 from the same period last year, while for Dec 2025 it was $0.11, marking a year-over-year decrease of 4981.34%. This contributed to the annual value of $0.11 for FY2025, which is 4981.34% down from last year.
- Latest data reveals that Ocular Therapeutix reported Debt to Equity of $0.11 as of Q4 2025, which was down 4981.34% from $0.27 recorded in Q3 2025.
- In the past 5 years, Ocular Therapeutix's Debt to Equity ranged from a high of $8.29 in Q3 2023 and a low of $0.11 during Q4 2025
- Its 5-year average for Debt to Equity is $1.19, with a median of $0.28 in 2021.
- Its Debt to Equity has fluctuated over the past 5 years, first skyrocketed by 187680.11% in 2023, then plummeted by 9767.7% in 2024.
- Over the past 5 years, Ocular Therapeutix's Debt to Equity (Quarter) stood at $0.28 in 2021, then skyrocketed by 151.29% to $0.71 in 2022, then grew by 1.12% to $0.72 in 2023, then crashed by 69.91% to $0.22 in 2024, then crashed by 49.81% to $0.11 in 2025.
- Its Debt to Equity was $0.11 in Q4 2025, compared to $0.27 in Q3 2025 and $0.23 in Q2 2025.